---
title: "Analysing Gene Expression of Breast Cancer patients"
format: 
  revealjs:
    theme: solarized
    transition: fade
    embed-resources: true
    logo: Corp_Red_RGB.png
    footer: "R4BDS - Group 28"
author: 
- "Iben Sommerand s203522"
- "Jonas Sennek s203516"
- "Emilie Wenner s193602"
- "Torbj√∏rn Bak Regueira s203555"
- "Vedis Arntzen s203546"
editor: visual
---

```{r}
#| include: false
library("tidyverse")
library("here")
library("table1")
```

```{r}
#| output: false
#| echo: false
#| warning: false
data <- read_tsv(file = here("data/03_dat_aug.tsv.gz"), 
                 na = "NA", 
                 guess_max = 1001
                 )
```


## Introduction

-   2 296 840 new breast cancer patients in 2022[^1].

-   Aim of project: Exploring and analyzing patterns in breast cancer gene expression data.

[^1]: [Breast Cancer Statistics](https://www.wcrf.org/preventing-cancer/cancer-statistics/breast-cancer-statistics/).

## Materials and Methods

-   The analysis was performed on the dataset "GDC TCGA Breast Cancer (BRCA)" from xenabrowser.net

-   Our data:

    -   Gene expression (RNAseq) and phenotype metadata


## Materials and Methods

```{r, echo=FALSE, fig.cap='Figure 1: Flowchart presenting an overview of the process from raw data to augmented data'}
knitr::include_graphics(path = here("doc/flowchart_proces.png"))

```

::: {.notes}
-   Data obtained programatically

-   Pivoted the gene expression dataset longer to be more tidy

-   The two datasets were joined on the patient IDs

-   Mutated the dataset to add new columns:

    -   Age groups
    -   Converted days to years for several relevant columns

-   Analytical methods:

    -   Descriptive data analysis, PCA and Linear Modelling
:::

## Descriptive analysis: Overview of the data

::: columns
::: {.column width="49%"}
```{r echo=FALSE, fig.cap='Figure 2: Gender and ethnicity distribution within the data'}
#| warning: false
data |>
  filter(!is.na(vital_status)) |>
  table1(x = formula(~ gender + ethnicity + age_group | vital_status),
         data = _)
```
:::

::: {.column width="51%"}
```{r echo=FALSE, fig.cap='Figure 3: Cancer stage distribution within the data'}
 knitr::include_graphics(path = here("results/data_description/people_per_stage.png"))
```
:::
:::

## Descriptive analysis: Vitality

::: {columns}
::: {.column width="45%"}
```{r echo=FALSE, fig.cap='Figure 4: Vitality based on cancer type'}
knitr::include_graphics(path = here("results/data_description/cancer_type_vitality_v2.png")) 

```
:::

::: {.column width="45%"}
```{r, echo=FALSE, fig.cap='Figure 5: Vitality by age'}
knitr::include_graphics(path = here("results/data_description/survival_by_age.png"))
```
:::
:::


## Analysis: Linear model

Show Jonas plot here

## Descriptive analysis: Vitality
::: {columns}
::: {.column width="45%"}
```{r echo=FALSE, fig.cap='Figure 6: Vitality based on cancer type'}
knitr::include_graphics(path = here("results/data_description/days_to_death_prior_malignancy.png"))
```
:::

::: {.column width="45%"}
```{r, echo=FALSE, fig.cap='Figure 7: Vitality by age'}
knitr::include_graphics(path = here("results/data_description/treatment_vs_therapy_v2.png"))
```
:::
:::


## Analysis: Investigating cancer stages

::: columns
::: {.column width="50%"}
```{r, echo=FALSE, fig.cap='Figure 8: Survival time by Cancer Stage'}
knitr::include_graphics(path=here("results/05_01_years_until_death_by_cancer_stage.png"))
```
:::

::: {.column width="50%"}
```{r, echo=FALSE, fig.cap='Figure 9: Vital Status by Cancer Stage'}
knitr::include_graphics(path = here("results/05_02_vital_status_by_cancer_stage.png"))
```
:::
:::

## Analysis: PCA


::: {columns}
::: {.column width="49%"}
```{r, echo=FALSE, fig.cap='Figure 10: Principal Component Analysis'}
knitr::include_graphics(path = here("results/06_pca_plot_2.png"))
```
:::

::: {.column width="49%"}
```{r, echo=FALSE, fig.cap='Figure 11: Scree plot'}
knitr::include_graphics(path = here("results/06_scree_plot_2.png"))
```
:::
:::

## Discussion:

-   Catching the cancer in an early stage seems to increase chance of survival

-   Limitations and future work

    -   Compare against healthy tissue samples (eg. GTEX)
